New, better antivirals against COVID-19 are on the way. On Friday, drug giant Merck announced it would seek FDA emergency use approval for a powerful new antiviral, molnupiravir. At least two more such drugs that target the SARS-CoV-2 virus are in the pipeline from other companies, and could save thousandsContinue Reading

Merck to seek emergency approval for its new COVID antiviral pill: In a trial of the drug molnupiravir, the risk of hospitalization and death was halved when given to high-risk patients within five days of infection. Read more Has the pandemic made the opioid epidemic worse? In interviews with HealthDayContinue Reading

CDC issues urgent plea for pregnant women to get vaccinated: With only a third of women in this group immunized, health officials made a strong push for getting the shots. Read more New report finds toxins in baby foods a continuing problem: Despite an earlier report that called for action,Continue Reading

Side effects of Pfizer booster shots are no different than with first two doses: The reassuring report comes as millions of Americans sign up for their third dose of the vaccine. Read more New tests for colon, prostate cancer show promise: In a pair of studies, just a sample ofContinue Reading

Delta variant convinced many to get vaccinated, poll finds: But the Kaiser Family Foundation’s latest survey also revealed that among unvaccinated Americans, nearly 75% say they believe the need for booster shots proves the vaccines don’t work. Read more Fruits, veggies a recipe for happiness in kids: A nutritious breakfastContinue Reading

Had COVID before and think you’re immune? Think again: Not all infections are created equal, with antibody responses varying wildly, experts say. Read more Retirees who cruise the internet stay sharp: Those who logged on more often posted substantially higher scores on thinking tests. Why is the million-dollar question. ReadContinue Reading

CDC approves booster shots for millions of Americans: In a rare move, CDC Director Dr. Rochelle Walensky said those who have jobs that make them vulnerable to COVID exposure can also get the extra doses. Read more COVID vaccines well worth it for cancer patients: A pair of clinical trialsContinue Reading